Laraib Safeer
Dermatology · Sugar Land, TXNPI 1285197319
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,402 and has fallen 77.9% since, to $310 in 2025. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.
Across 128 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$523
- LEO Pharma Inc.$371
- Amgen$297
- Sanofi$217
- Dermavant Sciences, Inc.$174
- Johnson & Johnson$167
- plus $735 from 13 others
What the payments were for
- Food & beverage$2,484100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $523 |
| LEO Pharma Inc. | 43 | $371 |
| Amgen | 13 | $297 |
| Sanofi | 5 | $217 |
| Dermavant Sciences, Inc. | 9 | $174 |
| Johnson & Johnson | 2 | $167 |
| Incyte Corporation | 6 | $116 |
| Lilly USA, LLC | 5 | $108 |
| UCB, Inc. | 3 | $95 |
| Novartis | 4 | $87 |
| E.r. Squibb & Sons, L.L.C. | 4 | $80 |
| Medtronic | 1 | $59 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| Pfizer | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,484 in reported general payments places this provider in the 40th percentile of 1,098 dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 19 | $74,762 |
| Clobetasol Propionate | 34 | $1,304 |
| Doxycycline Hyclate | 62 | $647 |
| Ketoconazole | 45 | $577 |
| Desonide | 16 | $538 |
| Gentamicin Sulfate | 13 | $427 |
| Triamcinolone Acetonide | 54 | $358 |
| Mupirocin | 48 | $244 |
| Naproxen | 31 | $30 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Sugar Land
- Vandana MadkanSugar Land$327K
- Michael SonabendSugar Land$184K
- Jennifer MaenderSugar Land$127K
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
- Ross RaduskyDallas$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.